Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Inventage Lab Inc. (389470:KRX), powered by AI.
Inventage Lab Inc. is currently trading at ₩46,000. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Inventage Lab Inc. on Alpha Lenz.
Inventage Lab Inc.'s P/E ratio is -72.4.
“Inventage Lab Inc. trades at a P/E of -72.4 (undervalued) with modest ROE of -17.4%.”
Ask for details →Inventage Lab Inc. is a pioneering biotechnology company that focuses on research and development in the pharmaceutical industry. The company's primary function is the innovation and production of advanced drug delivery systems and therapeutic solutions. With a strong commitment to improving patient outcomes, Inventage Lab Inc. leverages cutting-edge technology to streamline medication administration methods, ultimately enhancing efficacy and safety profiles. This includes developing smart drug delivery platforms that address complex medical challenges and unmet medical needs across various sectors. By collaborating with global pharmaceutical firms and research institutions, Inventage Lab Inc. plays a crucial role in accelerating the commercialization of novel medical therapies. The company's efforts contribute significantly to the broader healthcare market by offering scalable solutions that impact fields such as oncology, neurology, and chronic disease management, thus maintaining a vital position in the advancement of global healthcare solutions.
“Inventage Lab Inc. trades at a P/E of -72.4 (undervalued) with modest ROE of -17.4%.”
Ask for details →Inventage Lab Inc. (ticker: 389470) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). Market cap is $612.2B.
The current price is ₩46,000 with a P/E ratio of -72.37x and P/B of 9.5x.
ROE is -17.43% and operating margin is -965.74%. Annual revenue is $2.9B.